Literature DB >> 24219208

The Vulnerable Elders Survey-13 predicts mortality in older adults with later-stage colorectal cancer receiving chemotherapy: a prospective pilot study.

Erika Ramsdale1, Blase Polite, Joshua Hemmerich, Kathryn Bylow, Hedy L Kindler, Supriya Mohile, William Dale.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 24219208     DOI: 10.1111/jgs.12536

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  5 in total

1.  Which better predicts mortality among older men, a prostate cancer (PCa) diagnosis or vulnerability on the Vulnerable Elders Survey (VES-13)? A retrospective cohort study.

Authors:  Lisa M Lowenstein; Supriya G Mohile; Heather Hopkins Gil; Chintan Pandya; Joshua Hemmerich; Miriam Rodin; William Dale
Journal:  J Geriatr Oncol       Date:  2016-07-30       Impact factor: 3.599

Review 2.  Integration of Geriatric Assessment in the Care of Patients with Gastrointestinal Malignancies.

Authors:  Siri Rostoft
Journal:  Visc Med       Date:  2017-08-03

3.  Predicting Chemotherapy Toxicity and Death in Older Adults with Colon Cancer: Results of MOST Study.

Authors:  Frédérique Retornaz; Olivier Guillem; Frédérique Rousseau; Francois Morvan; Yves Rinaldi; Sophie Nahon; Chantal Castagna; Rabia Boulahssass; Michel Grino; Dany Gholam
Journal:  Oncologist       Date:  2019-08-06

Review 4.  How should older adults with cancer be evaluated for frailty?

Authors:  Megan Huisingh-Scheetz; Jeremy Walston
Journal:  J Geriatr Oncol       Date:  2016-06-16       Impact factor: 3.599

5.  Prospective evaluation of the G8 screening tool for prognostication of survival in elderly patients with lung cancer: A single-institution study.

Authors:  Yoko Agemi; Tsuneo Shimokawa; Jiichiro Sasaki; Kazuhito Miyazaki; Yuki Misumi; Akira Sato; Shinzi Aida; Mari Ishii; Yukiko Nakamura; Katsuhiko Naoki; Hiroaki Okamoto
Journal:  PLoS One       Date:  2019-01-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.